 | • レポートコード：QYR9N7874 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、精密癌診断テストのグローバル市場について調査・分析したレポートで、種類別（イメージング、分子、組織学/細胞診、腫瘍マーカーイムノアッセイ、POC大腸がん検査）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・精密癌診断テストの世界市場規模 ・主要企業別市場シェア ・精密癌診断テストの世界市場規模：種類別（イメージング、分子、組織学/細胞診、腫瘍マーカーイムノアッセイ、POC大腸がん検査） ・精密癌診断テストの世界市場規模：用途別（病院、診療所、その他） ・精密癌診断テストのアメリカ市場規模（種類別、用途別） ・精密癌診断テストのヨーロッパ市場規模（種類別、用途別） ・精密癌診断テストの中国市場規模（種類別、用途別） ・精密癌診断テストの日本市場規模（種類別、用途別） ・精密癌診断テストの東南アジア市場規模（種類別、用途別） ・精密癌診断テストのインド市場規模（種類別、用途別） ・精密癌診断テストの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・精密癌診断テストの世界市場予測（2019年-2025年） ・精密癌診断テストの地域別市場予測（2019年-2025年） ... |
Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves. In 2018, the global Precision Cancer Diagnostic Tests market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Precision Cancer Diagnostic Tests status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Precision Cancer Diagnostic Tests development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Agilent Technologies, Inc.
Becton Dickinson and Company
Bio-Rad Laboratories, Inc.
Biocartis N.V.
Biocept, Inc.
bioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems, Inc.
Danaher Corporation
Epigenomics AG
Exosome Diagnostics, Inc.
Foundation Medicine, Inc.
General Electric Company
Genomic Health, Inc.
Hologic, Inc.
Illumina, Inc.
Menarini Silicon Biosystems SpA
Myriad Genetics, Inc.
NanoString Technologies, Inc.
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics
Market segment by Type, the product can be split into
Imaging
Molecular
Histology/Cytology
Tumor Marker Immunoassays
POC Colon Cancer Tests
Market segment by Application, split into
Hospital
Clinic
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Precision Cancer Diagnostic Tests status, future forecast, growth opportunity, key market and key players.
To present the Precision Cancer Diagnostic Tests development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Precision Cancer Diagnostic Tests are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type (2014-2025)
1.4.2 Imaging
1.4.3 Molecular
1.4.4 Histology/Cytology
1.4.5 Tumor Marker Immunoassays
1.4.6 POC Colon Cancer Tests
1.5 Market by Application
1.5.1 Global Precision Cancer Diagnostic Tests Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Precision Cancer Diagnostic Tests Market Size
2.2 Precision Cancer Diagnostic Tests Growth Trends by Regions
2.2.1 Precision Cancer Diagnostic Tests Market Size by Regions (2014-2025)
2.2.2 Precision Cancer Diagnostic Tests Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Precision Cancer Diagnostic Tests Market Size by Manufacturers
3.1.1 Global Precision Cancer Diagnostic Tests Revenue by Manufacturers (2014-2019)
3.1.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Precision Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.2 Precision Cancer Diagnostic Tests Key Players Head office and Area Served
3.3 Key Players Precision Cancer Diagnostic Tests Product/Solution/Service
3.4 Date of Enter into Precision Cancer Diagnostic Tests Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Precision Cancer Diagnostic Tests Market Size by Type (2014-2019)
4.2 Global Precision Cancer Diagnostic Tests Market Size by Application (2014-2019)
5 United States
5.1 United States Precision Cancer Diagnostic Tests Market Size (2014-2019)
5.2 Precision Cancer Diagnostic Tests Key Players in United States
5.3 United States Precision Cancer Diagnostic Tests Market Size by Type
5.4 United States Precision Cancer Diagnostic Tests Market Size by Application
6 Europe
6.1 Europe Precision Cancer Diagnostic Tests Market Size (2014-2019)
6.2 Precision Cancer Diagnostic Tests Key Players in Europe
6.3 Europe Precision Cancer Diagnostic Tests Market Size by Type
6.4 Europe Precision Cancer Diagnostic Tests Market Size by Application
7 China
7.1 China Precision Cancer Diagnostic Tests Market Size (2014-2019)
7.2 Precision Cancer Diagnostic Tests Key Players in China
7.3 China Precision Cancer Diagnostic Tests Market Size by Type
7.4 China Precision Cancer Diagnostic Tests Market Size by Application
8 Japan
8.1 Japan Precision Cancer Diagnostic Tests Market Size (2014-2019)
8.2 Precision Cancer Diagnostic Tests Key Players in Japan
8.3 Japan Precision Cancer Diagnostic Tests Market Size by Type
8.4 Japan Precision Cancer Diagnostic Tests Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Precision Cancer Diagnostic Tests Market Size (2014-2019)
9.2 Precision Cancer Diagnostic Tests Key Players in Southeast Asia
9.3 Southeast Asia Precision Cancer Diagnostic Tests Market Size by Type
9.4 Southeast Asia Precision Cancer Diagnostic Tests Market Size by Application
10 India
10.1 India Precision Cancer Diagnostic Tests Market Size (2014-2019)
10.2 Precision Cancer Diagnostic Tests Key Players in India
10.3 India Precision Cancer Diagnostic Tests Market Size by Type
10.4 India Precision Cancer Diagnostic Tests Market Size by Application
11 Central & South America
11.1 Central & South America Precision Cancer Diagnostic Tests Market Size (2014-2019)
11.2 Precision Cancer Diagnostic Tests Key Players in Central & South America
11.3 Central & South America Precision Cancer Diagnostic Tests Market Size by Type
11.4 Central & South America Precision Cancer Diagnostic Tests Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Precision Cancer Diagnostic Tests Introduction
12.1.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Agilent Technologies, Inc.
12.2.1 Agilent Technologies, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Precision Cancer Diagnostic Tests Introduction
12.2.4 Agilent Technologies, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
12.2.5 Agilent Technologies, Inc. Recent Development
12.3 Becton Dickinson and Company
12.3.1 Becton Dickinson and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Precision Cancer Diagnostic Tests Introduction
12.3.4 Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
12.3.5 Becton Dickinson and Company Recent Development
12.4 Bio-Rad Laboratories, Inc.
12.4.1 Bio-Rad Laboratories, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Precision Cancer Diagnostic Tests Introduction
12.4.4 Bio-Rad Laboratories, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
12.4.5 Bio-Rad Laboratories, Inc. Recent Development
12.5 Biocartis N.V.
12.5.1 Biocartis N.V. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Precision Cancer Diagnostic Tests Introduction
12.5.4 Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
12.5.5 Biocartis N.V. Recent Development
12.6 Biocept, Inc.
12.6.1 Biocept, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Precision Cancer Diagnostic Tests Introduction
12.6.4 Biocept, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
12.6.5 Biocept, Inc. Recent Development
12.7 bioMerieux SA
12.7.1 bioMerieux SA Company Details
12.7.2 Company Description and Business Overview
12.7.3 Precision Cancer Diagnostic Tests Introduction
12.7.4 bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
12.7.5 bioMerieux SA Recent Development
12.8 Canon Medical Systems Corporation
12.8.1 Canon Medical Systems Corporation Company Details
12.8.2 Company Description and Business Overview
12.8.3 Precision Cancer Diagnostic Tests Introduction
12.8.4 Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
12.8.5 Canon Medical Systems Corporation Recent Development
12.9 Cynvenio Biosystems, Inc.
12.9.1 Cynvenio Biosystems, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Precision Cancer Diagnostic Tests Introduction
12.9.4 Cynvenio Biosystems, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
12.9.5 Cynvenio Biosystems, Inc. Recent Development
12.10 Danaher Corporation
12.10.1 Danaher Corporation Company Details
12.10.2 Company Description and Business Overview
12.10.3 Precision Cancer Diagnostic Tests Introduction
12.10.4 Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)
12.10.5 Danaher Corporation Recent Development
12.11 Epigenomics AG
12.12 Exosome Diagnostics, Inc.
12.13 Foundation Medicine, Inc.
12.14 General Electric Company
12.15 Genomic Health, Inc.
12.16 Hologic, Inc.
12.17 Illumina, Inc.
12.18 Menarini Silicon Biosystems SpA
12.19 Myriad Genetics, Inc.
12.20 NanoString Technologies, Inc.
12.21 Ortho Clinical Diagnostics
12.22 QIAGEN N.V.
12.23 Randox Laboratories Ltd.
12.24 Roche Holding AG
12.25 Royal Philips N.V.
12.26 Siemens AG
12.27 Thermo Fisher Scientific
12.28 Vela Diagnostics
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Precision Cancer Diagnostic Tests Key Market Segments
Table Key Players Precision Cancer Diagnostic Tests Covered
Table Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Precision Cancer Diagnostic Tests Market Size Market Share by Type 2014-2025
Figure Imaging Figures
Table Key Players of Imaging
Figure Molecular Figures
Table Key Players of Molecular
Figure Histology/Cytology Figures
Table Key Players of Histology/Cytology
Figure Tumor Marker Immunoassays Figures
Table Key Players of Tumor Marker Immunoassays
Figure POC Colon Cancer Tests Figures
Table Key Players of POC Colon Cancer Tests
Table Global Precision Cancer Diagnostic Tests Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Other Case Studies
Figure Precision Cancer Diagnostic Tests Report Years Considered
Table Global Precision Cancer Diagnostic Tests Market Size 2014-2025 (Million US$)
Figure Global Precision Cancer Diagnostic Tests Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Precision Cancer Diagnostic Tests Market Size by Regions 2014-2025 (Million US$)
Table Global Precision Cancer Diagnostic Tests Market Size by Regions 2014-2019 (Million US$)
Table Global Precision Cancer Diagnostic Tests Market Share by Regions 2014-2019
Figure Global Precision Cancer Diagnostic Tests Market Share by Regions 2014-2019
Figure Global Precision Cancer Diagnostic Tests Market Share by Regions 2019
Table Market Top Trends
Table Global Precision Cancer Diagnostic Tests Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Precision Cancer Diagnostic Tests Market Share by Manufacturers (2014-2019)
Figure Global Precision Cancer Diagnostic Tests Market Share by Manufacturers in 2018
Table Global Precision Cancer Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Precision Cancer Diagnostic Tests Product/Solution/Service
Table Date of Enter into Precision Cancer Diagnostic Tests Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Precision Cancer Diagnostic Tests Market Size by Type (2014-2019) (Million US$)
Table Global Precision Cancer Diagnostic Tests Market Size Share by Type (2014-2019)
Figure Global Precision Cancer Diagnostic Tests Market Size Market Share by Type (2014-2019)
Table Global Precision Cancer Diagnostic Tests Market Size by Application (2014-2019) (Million US$)
Table Global Precision Cancer Diagnostic Tests Market Size Share by Application (2014-2019)
Figure Global Precision Cancer Diagnostic Tests Market Size Market Share by Application (2014-2019)
Figure Global Precision Cancer Diagnostic Tests Revenue Market Share by Application in 2018
Figure United States Precision Cancer Diagnostic Tests Market Size 2014-2019 (Million US$)
Table United States Key Players Precision Cancer Diagnostic Tests Revenue (2018-2019) (Million US$)
Table United States Key Players Precision Cancer Diagnostic Tests Market Share (2018-2019)
Table United States Precision Cancer Diagnostic Tests Market Size by Type (2014-2019) (Million US$)
Table United States Precision Cancer Diagnostic Tests Market Share by Type (2014-2019)
Table United States Precision Cancer Diagnostic Tests Market Size by Application (2014-2019) (Million US$)
Table United States Precision Cancer Diagnostic Tests Market Share by Application (2014-2019)
Figure Europe Precision Cancer Diagnostic Tests Market Size 2014-2019 (Million US$)
Table Europe Key Players Precision Cancer Diagnostic Tests Revenue (2018-2019) (Million US$)
Table Europe Key Players Precision Cancer Diagnostic Tests Market Share (2018-2019)
Table Europe Precision Cancer Diagnostic Tests Market Size by Type (2014-2019) (Million US$)
Table Europe Precision Cancer Diagnostic Tests Market Share by Type (2014-2019)
Table Europe Precision Cancer Diagnostic Tests Market Size by Application (2014-2019) (Million US$)
Table Europe Precision Cancer Diagnostic Tests Market Share by Application (2014-2019)
Figure China Precision Cancer Diagnostic Tests Market Size 2014-2019 (Million US$)
Table China Key Players Precision Cancer Diagnostic Tests Revenue (2018-2019) (Million US$)
Table China Key Players Precision Cancer Diagnostic Tests Market Share (2018-2019)
Table China Precision Cancer Diagnostic Tests Market Size by Type (2014-20189) (Million US$)
Table China Precision Cancer Diagnostic Tests Market Share by Type (2014-2019)
Table China Precision Cancer Diagnostic Tests Market Size by Application (2014-2019) (Million US$)
Table China Precision Cancer Diagnostic Tests Market Share by Application (2014-2019)
Figure Japan Precision Cancer Diagnostic Tests Market Size 2014-2019 (Million US$)
Table Japan Key Players Precision Cancer Diagnostic Tests Revenue (2018-2019) (Million US$)
Table Japan Key Players Precision Cancer Diagnostic Tests Market Share (2018-2019)
Table Japan Precision Cancer Diagnostic Tests Market Size by Type (2014-2019) (Million US$)
Table Japan Precision Cancer Diagnostic Tests Market Share by Type (2014-2019)
Table Japan Precision Cancer Diagnostic Tests Market Size by Application (2014-2019) (Million US$)
Table Japan Precision Cancer Diagnostic Tests Market Share by Application (2014-2019)
Figure Southeast Asia Precision Cancer Diagnostic Tests Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Precision Cancer Diagnostic Tests Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Precision Cancer Diagnostic Tests Market Share (2018-2019)
Table Southeast Asia Precision Cancer Diagnostic Tests Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Precision Cancer Diagnostic Tests Market Share by Type (2014-2019)
Table Southeast Asia Precision Cancer Diagnostic Tests Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Precision Cancer Diagnostic Tests Market Share by Application (2014-2019)
Figure India Precision Cancer Diagnostic Tests Market Size 2014-2019 (Million US$)
Table India Key Players Precision Cancer Diagnostic Tests Revenue (2018-2019) (Million US$)
Table India Key Players Precision Cancer Diagnostic Tests Market Share (2018-2019)
Table India Precision Cancer Diagnostic Tests Market Size by Type (2014-2019) (Million US$)
Table India Precision Cancer Diagnostic Tests Market Share by Type (2014-2019)
Table India Precision Cancer Diagnostic Tests Market Size by Application (2014-2019) (Million US$)
Table India Precision Cancer Diagnostic Tests Market Share by Application (2014-2019)
Figure Central & South America Precision Cancer Diagnostic Tests Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Precision Cancer Diagnostic Tests Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Precision Cancer Diagnostic Tests Market Share (2018-2019)
Table Central & South America Precision Cancer Diagnostic Tests Market Size by Type (2014-2019) (Million US$)
Table Central & South America Precision Cancer Diagnostic Tests Market Share by Type (2014-2019)
Table Central & South America Precision Cancer Diagnostic Tests Market Size by Application (2014-2019) (Million US$)
Table Central & South America Precision Cancer Diagnostic Tests Market Share by Application (2014-2019)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2014-2019) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Agilent Technologies, Inc. Company Details
Table Agilent Technologies, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)(Million US$)
Figure Agilent Technologies, Inc. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2014-2019)
Table Agilent Technologies, Inc. Recent Development
Table Becton Dickinson and Company Company Details
Table Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)(Million US$)
Figure Becton Dickinson and Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2014-2019)
Table Becton Dickinson and Company Recent Development
Table Bio-Rad Laboratories, Inc. Company Details
Table Bio-Rad Laboratories, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)(Million US$)
Figure Bio-Rad Laboratories, Inc. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2014-2019)
Table Bio-Rad Laboratories, Inc. Recent Development
Table Biocartis N.V. Company Details
Table Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)(Million US$)
Figure Biocartis N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2014-2019)
Table Biocartis N.V. Recent Development
Table Biocept, Inc. Company Details
Table Biocept, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)(Million US$)
Figure Biocept, Inc. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2014-2019)
Table Biocept, Inc. Recent Development
Table bioMerieux SA Company Details
Table bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)(Million US$)
Figure bioMerieux SA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2014-2019)
Table bioMerieux SA Recent Development
Table Canon Medical Systems Corporation Company Details
Table Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)(Million US$)
Figure Canon Medical Systems Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2014-2019)
Table Canon Medical Systems Corporation Recent Development
Table Cynvenio Biosystems, Inc. Company Details
Table Cynvenio Biosystems, Inc. Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)(Million US$)
Figure Cynvenio Biosystems, Inc. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2014-2019)
Table Cynvenio Biosystems, Inc. Recent Development
Table Danaher Corporation Company Details
Table Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2014-2019)(Million US$)
Figure Danaher Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2014-2019)
Table Danaher Corporation Recent Development
Table Epigenomics AG Company Details
Table Exosome Diagnostics, Inc. Company Details
Table Foundation Medicine, Inc. Company Details
Table General Electric Company Company Details
Table Genomic Health, Inc. Company Details
Table Hologic, Inc. Company Details
Table Illumina, Inc. Company Details
Table Menarini Silicon Biosystems SpA Company Details
Table Myriad Genetics, Inc. Company Details
Table NanoString Technologies, Inc. Company Details
Table Ortho Clinical Diagnostics Company Details
Table QIAGEN N.V. Company Details
Table Randox Laboratories Ltd. Company Details
Table Roche Holding AG Company Details
Table Royal Philips N.V. Company Details
Table Siemens AG Company Details
Table Thermo Fisher Scientific Company Details
Table Vela Diagnostics Company Details
Table Global Precision Cancer Diagnostic Tests Market Size by Regions (Million US$) 2019-2025
Figure Global Precision Cancer Diagnostic Tests Market Size Share by Regions (2019-2025)
Figure Global Precision Cancer Diagnostic Tests Market Size Share by Regions in 2025
Figure United States Precision Cancer Diagnostic Tests Market Size Forecast (2019-2025)(Million USD)
Figure Europe Precision Cancer Diagnostic Tests Market Size Forecast (2019-2025)(Million USD)
Figure China Precision Cancer Diagnostic Tests Market Size Forecast (2019-2025)(Million USD)
Figure Japan Precision Cancer Diagnostic Tests Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Precision Cancer Diagnostic Tests Market Size Forecast (2019-2025)(Million USD)
Figure India Precision Cancer Diagnostic Tests Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Precision Cancer Diagnostic Tests Market Size Forecast (2019-2025)(Million USD)
Table Global Precision Cancer Diagnostic Tests Market Size by Product (2019-2025) (Million US$)
Figure Global Precision Cancer Diagnostic Tests Market Size by Product (2019-2025)
Figure Global Precision Cancer Diagnostic Tests Market Size by Product in 2025
Table Global Precision Cancer Diagnostic Tests Market Size by Application (2019-2025) (Million US$)
Figure Global Precision Cancer Diagnostic Tests Market Size by Application (2019-2025)
Figure Global Precision Cancer Diagnostic Tests Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の前立腺がんのスクリーニング市場：市場規模・現状・予測 Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measur…- 世界の精密がん治療市場：市場規模・現状・予測 Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalit…
- 世界の膵がんの診断市場：市場規模・現状・予測 Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. This report studies the Pancreatic Cancer Diagnostic market, includes Tumor Biomarker Tests, Imaging, Bio…
- 世界の甲状腺がん検査市場：市場規模・現状・予測 Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones.The global thyroid cancer testing is expected to show significant growth over the forecast period. Increasing prevalence of thyroid cancer, technologica…
- 世界の腫瘍バイオマーカー検査市場：市場規模・現状・予測 In 2018, the global Tumor Biomarker Test market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Tumor Biomarker Test status, future forecast, growth opportunity, key market and key players. The study …